L 30
Code | Size | Price |
---|
TAR-T24283-5mg | 5mg | £850.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T24283-50mg | 50mg | £1,661.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T24283-100mg | 100mg | £2,079.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Images
Documents
Further Information
Bioactivity:
L 30 is a blocker of the sodium channel.
CAS:
21236-52-2
Formula:
C15H24N2O
Molecular Weight:
248.37
Purity:
0.98
SMILES:
CCN(CC)CCC(=O)Nc1c(C)cccc1C
References
1. Tangoh DA, Apinjoh TO, Mahmood Y, Nyingchu RV, Tangunyi BA, Nji EN, Azhar A, Achidi EA. Vitamin D Status and Its Associated Risk Factors among Adults in the Southwest Region of Cameroon. J Nutr Metab. 2018 Mar 19;2018:4742574. doi: 10.1155/2018/4742574. eCollection 2018. PubMed PMID: 29750125; PubMed Central PMCID: PMC5884209.
2. Li J, Wu DD, Zhang JX, Wang J, Ma JJ, Hu X, Dong WG. Mitochondrial pathway mediated by reactive oxygen species involvement in ?-hederin-induced apoptosis in hepatocellular carcinoma cells. World J Gastroenterol. 2018 May 7;24(17):1901-1910. doi: 10.3748/wjg.v24.i17.1901. PubMed PMID: 29740205; PubMed Central PMCID: PMC5937207.
3. Fukuyama T, Yamauchi S, Amagasa S, Hattori Y, Sasaki T, Nakajima H, Takei Y, Okuno J, Misawa Y, Fueki N, Kitamura M, Matsui H, Inaba Y, Hirabayashi S. Early prognostic factors for acute encephalopathy with reduced subcortical diffusion. Brain Dev. 2018 Apr 28. pii: S0387-7604(18)30148-7. doi: 10.1016/j.braindev.2018.04.005. [Epub ahead of print] PubMed PMID: 29716832.
4. Barber RL, Ekin AE, Sivakumar P, Howard K, O'Sullivan TA. Glucose Gel as a Potential Alternative Treatment to Infant Formula for Neonatal Hypoglycaemia in Australia. Int J Environ Res Public Health. 2018 Apr 27;15(5). pii: E876. doi: 10.3390/ijerph15050876. PubMed PMID: 29702618.